Karuna Therapeutics Future Growth
Future criteria checks 5/6
Karuna Therapeutics is forecast to grow earnings and revenue by 60.1% and 52.1% per annum respectively. EPS is expected to grow by 60.1% per annum. Return on equity is forecast to be -28.9% in 3 years.
Key information
60.1%
Earnings growth rate
60.1%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | 52.1% |
| Future return on equity | -28.9% |
| Analyst coverage | Good |
| Last updated | 16 Mar 2024 |
Recent future growth updates
Recent updates
Karuna Therapeutics: Getting Sold Short
Feb 18We're Hopeful That Karuna Therapeutics (NASDAQ:KRTX) Will Use Its Cash Wisely
Sep 26
We're Not Very Worried About Karuna Therapeutics' (NASDAQ:KRTX) Cash Burn Rate
Jun 05Here's Why We're Not At All Concerned With Karuna Therapeutics' (NASDAQ:KRTX) Cash Burn Situation
Feb 20Karuna Therapeutics, Inc. (NASDAQ:KRTX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Nov 06Best Performing Stocks
Sep 23Karuna Therapeutics: This Ship Has Sailed
Sep 09Karuna Therapeutics GAAP EPS of -$2.17 misses by $0.10, revenue of $5.28M
Aug 08Karuna Therapeutics: Front-Running KarXT Phase 3
Jun 26Karuna Therapeutics (NASDAQ:KRTX) Is In A Good Position To Deliver On Growth Plans
May 10Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 690 | 38 | 306 | 344 | 11 |
| 12/31/2025 | 257 | -331 | -155 | -233 | 15 |
| 12/31/2024 | 61 | -445 | -426 | -441 | 16 |
| 12/31/2023 | 1 | -434 | -389 | -386 | N/A |
| 9/30/2023 | 6 | -396 | -356 | -354 | N/A |
| 6/30/2023 | 6 | -354 | -305 | -303 | N/A |
| 3/31/2023 | 11 | -316 | -280 | -279 | N/A |
| 12/31/2022 | 11 | -276 | -229 | -228 | N/A |
| 9/30/2022 | 42 | -228 | -158 | -156 | N/A |
| 6/30/2022 | 42 | -202 | -143 | -140 | N/A |
| 3/31/2022 | 37 | -172 | -133 | -130 | N/A |
| 12/31/2021 | 37 | -144 | -104 | -101 | N/A |
| 9/30/2021 | N/A | -140 | -119 | -117 | N/A |
| 6/30/2021 | N/A | -108 | -97 | -96 | N/A |
| 3/31/2021 | N/A | -90 | -83 | -83 | N/A |
| 12/31/2020 | N/A | -69 | -70 | -70 | N/A |
| 9/30/2020 | N/A | -52 | -54 | -54 | N/A |
| 6/30/2020 | N/A | -43 | -40 | -39 | N/A |
| 3/31/2020 | N/A | -41 | -33 | -33 | N/A |
| 12/31/2019 | N/A | -44 | -31 | -31 | N/A |
| 9/30/2019 | N/A | -45 | -31 | -31 | N/A |
| 6/30/2019 | N/A | -42 | -25 | -25 | N/A |
| 3/31/2019 | N/A | -27 | -21 | -21 | N/A |
| 12/31/2018 | N/A | -18 | -16 | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KRTX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: KRTX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: KRTX is expected to become profitable in the next 3 years.
Revenue vs Market: KRTX's revenue (52.1% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: KRTX's revenue (52.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KRTX is forecast to be unprofitable in 3 years.